Simmons S A, Payne B C, Smith M C
J Health Care Mark. 1986 Sep;6(3):29-36.
The cost of drugs dispensed through the Medicaid program is the focus of this article. The research question addressed is, "What variables raise or lower the expense of marketing drugs to Medicaid recipients?" Medicaid drug programs are dichotomized into high- and low-cost groups and variables are identified that are linked with either the more or less expensive programs. Three groups should be interested in identifying factors that increase or decrease the cost of marketing drugs to Medicaid patients--pharmacy managers, Medicaid administrators at the state and federal levels, and public aid recipients.